What is the recommended treatment for cutaneous larva migrans and visceral larva migrans?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 9, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Treatment of Larva Migrans

Cutaneous Larva Migrans

For cutaneous larva migrans, treat with either ivermectin 200 μg/kg as a single oral dose OR albendazole 400 mg once daily for 3 days. 1

First-Line Treatment Options

Both regimens are equally recommended as first-line therapy by the most recent UK guidelines 1:

  • Ivermectin 200 μg/kg PO single dose - This achieves cure rates approaching 95-100% and offers the convenience of single-dose administration 2
  • Albendazole 400 mg PO once daily for 3 days - Equally effective alternative with excellent tolerability 1

Clinical Diagnosis and Presentation

Diagnosis is made clinically without need for laboratory confirmation 1:

  • Characteristic self-limiting itchy, serpiginous rash migrating at 1-2 cm per day 1
  • Caused by penetration of skin by dog/cat hookworm larvae (Ancylostoma braziliense, Ancylostoma caninum) 2
  • May be associated with peripheral eosinophilia 1
  • Critical distinction: This differs from "ground itch," which is a blister-like eruption at the point of entry of human hookworm larvae (Ancylostoma duodenale/Necator americanus) that proceeds to systemic infection 1, 3

Extended Treatment for Complex Cases

For patients with multiple or extensive lesions, consider extending albendazole to 7 days (400 mg daily), which achieves 100% cure rates and may reduce recurrence risk without increased side effects 2, 4. However, the standard 3-day course remains adequate for most cases 2.

Expected Clinical Response

  • Pruritus typically resolves within 2-3 days of treatment 4
  • Skin lesions disappear within 5-7 days 4
  • Important pitfall: Persistent itching after treatment does not indicate treatment failure—pruritus can persist for several days due to inflammatory response even after successful parasite eradication 2

Special Populations

Pregnancy: 2

  • Ivermectin has shown no teratogenicity in limited human data (American College of Obstetricians and Gynecologists), though caution is warranted
  • Albendazole should ideally be avoided, especially in the first trimester

Breastfeeding: Both ivermectin and albendazole appear compatible based on low excretion into breast milk (World Health Organization) 2

Renal impairment: No dose adjustments required for ivermectin 2

Severe liver disease: Safety of multiple ivermectin doses not established 2


Visceral Larva Migrans (Toxocariasis)

While the provided evidence focuses primarily on cutaneous larva migrans, visceral larva migrans (caused by Toxocara canis or Toxocara cati) is a distinct entity requiring different management. Based on standard parasitology principles, visceral larva migrans typically requires albendazole 400 mg twice daily for 5 days, though specialist consultation is advisable for confirmed cases given potential for serious organ involvement including ocular and neurologic manifestations.

References

Guideline

Treatment of Cutaneous Larva Migrans

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Cutaneous Larva Migrans Epidemiology and Clinical Distinctions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the recommended next‑line therapy for a patient with cutaneous larva migrans who has not improved after treatment with ivermectin and permethrin?
What is the recommended dose of ivermectin for the treatment of cutaneous larva migrans?
How long does it take for cutaneous larva migrans to disappear after treatment?
Which anthelmintic medications, dosages, and administration schedules should be used in dogs and cats to prevent cutaneous larva migrans?
What is the appropriate treatment for cutaneous larva migrans in a 4-year-old child?
Why is my blood glucose still high (≈330 mg/dL post‑meal, 283 mg/dL overnight, 281 mg/dL fasting) despite a basal insulin glargine (Lantus) dose of 50 units, a bolus carbohydrate ratio of 1 unit per 8 g carbohydrate, and a correction factor of 1 unit per 25 mg/dL, and what adjustments should be made?
What is the immediate next step in managing a patient who develops altered mental status immediately after a dialysis session?
Can Levoxyl (levothyroxine sodium) be used interchangeably with generic levothyroxine?
What are the adverse effects of glucagon-like peptide‑2 (GLP‑2) therapy, specifically teduglutide, in patients with short‑bowel syndrome?
How quickly does blood pressure rise after abruptly stopping olmesartan, and is tapering required to avoid rebound hypertension?
Is it safe for a pregnant woman with asthma to continue low‑dose inhaled corticosteroids (e.g., budesonide, fluticasone, beclomethasone) during the second trimester?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.